Patents by Inventor Ludwig Englmeier

Ludwig Englmeier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROPHYLAXIS AND TREATMENT OF CORONAVIRUS INFECTION
    Publication number: 20230338395
    Abstract: The present invention relates to the use of antagonists of tlr7-signalling for the treatment of COVID-19 patients, wherein the antagonists of tlr7-signalling are administered only after serovonversion. The invention also relates to a tlr agonist for use in the one-time prophylactic treatment of a subpopulation against an infection with a coronavirus, wherein the subpopulation is a collection of asymptomatic subjects in proximity to subjects of the population who show symptoms of infection.
    Type: Application
    Filed: April 17, 2021
    Publication date: October 26, 2023
    Inventor: Ludwig Englmeier
  • Pharmaceutical Compositions of a Benzothiophene Compound
    Publication number: 20200093821
    Abstract: The present invention discloses possibilities to make use of a substance or a material arranged to block, absorb and/or reflect UV exposure of a certain wavelength region to reduce or prevent UV-induced dimerization and optionally further UV-induced brexpiprazole impurities of brexpiprazole in a brexpiprazole dihydrate comprising pharmaceutical composition.
    Type: Application
    Filed: August 11, 2017
    Publication date: March 26, 2020
    Applicant: Hexal AG
    Inventors: Andreas Krekeler, Dimitri Neumann, Helmut Lasinger, Herbert Silberberger, Ludwig Englmeier
  • PHARMACEUTICAL COMPOSITION CONTAINING CRYSTALLINE MACITENTAN
    Publication number: 20180008603
    Abstract: The present invention relates to an oral solid dosage form, in particular a tablet, comprising macitentan free base polymorphic form I.
    Type: Application
    Filed: July 10, 2017
    Publication date: January 11, 2018
    Inventors: Marijan Stefinovic, Johannes Raneburger, Ludwig Englmeier
  • Pharmaceutical composition containing crystalline macitentan
    Patent number: 9730932
    Abstract: The present invention relates to an oral solid dosage form, in particular a tablet, comprising macitentan free base polymorphic form I.
    Type: Grant
    Filed: April 17, 2014
    Date of Patent: August 15, 2017
    Assignee: SANDOZ AG
    Inventors: Marijan Stefinovic, Johannes Raneburger, Ludwig Englmeier
  • TABLET WITH INCREASED DRUG LOAD OF ODANACATIB
    Publication number: 20160106679
    Abstract: The present invention relates to pharmaceutical tablets comprising amorphous compound I in the form of its free base or pharmaceutically acceptable salts of compound I.
    Type: Application
    Filed: May 16, 2014
    Publication date: April 21, 2016
    Inventors: Johannes Raneburger, Ludwig Englmeier, Andreas Krekeler, Michael Sedlmayr
  • TABLET WITH INCREASED DRUG LOAD OF ODANACATIB
    Publication number: 20160081937
    Abstract: The present invention relates to pharmaceutical tablets comprising amorphous compound I or pharmaceutically acceptable salts thereof, and an inert organic carrier.
    Type: Application
    Filed: May 16, 2014
    Publication date: March 24, 2016
    Inventors: Johannes Raneburger, Ludwig Englmeier, Andreas Krekeler, Michael Sedlmayr
  • PHARMACEUTICAL COMPOSITION CONTAINING CRYSTALLINE MACITENTAN
    Publication number: 20160074398
    Abstract: The present invention relates to an oral solid dosage form, in particular a tablet, comprising macitentan free base polymorphic form I.
    Type: Application
    Filed: April 17, 2014
    Publication date: March 17, 2016
    Inventors: Marijan Stefinovic, Johannes Raneburger, Ludwig Englmeier